LRRC15 and neoplasm: Tumours from DT-treated DTR– mice had a predominant population of LRRC15+ CAFs, whereas DT treatment in DTR+ tumours resulted in an approximately 98% loss of total LRRC15+ cells (Fig. 2b,c).